Angiotensin II-mediated development of vascular diseases

被引:119
作者
Daugherty, A
Cassis, L
机构
[1] Univ Kentucky, Dept Med, Div Cardiovasc Med, Gill Heart Inst, Lexington, KY 40536 USA
[2] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA
[3] Univ Kentucky, Grad Ctr Nutr Sci, Lexington, KY 40536 USA
[4] Univ Kentucky, Div Pharmaceut Sci, Lexington, KY USA
关键词
D O I
10.1016/j.tcm.2004.01.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Angiotensin II (AngII) has well-characterized effects on blood pressure and fluid balance that adversely affect atherosclerotic cardiovascular disease. More recently, there is a realization that AngII exerts direct effects on arterial wall cells to influence atherosclerotic lesion formation. Several groups have shown that infusion of AngII into hyperlipidemic mice rapidly and profoundly augments lesion formation. The increase in lesions front AngII was not attributable to elevated blood pressure. The lesions formed from, AngII infusion are overtly similar to those formed during hypercholesterolemia, with infiltration of macrophages and T lymphocytes. Unexpectedly, AngII infusion into these mice also led to the development of abdominal aortic aneurysms. These aneurysms exhibit many aspects of the human disease including medial degeneration, inflammation, thrombus, and rupture. The definition of the cellular mechanisms by which Ang II promotes these vascular pathologies may provide new therapeutic strategies.
引用
收藏
页码:117 / 120
页数:4
相关论文
共 36 条
[1]   Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis [J].
Boring, L ;
Gosling, J ;
Cleary, M ;
Charo, IF .
NATURE, 1998, 394 (6696) :894-897
[2]   LRP: Role in vascular wall integrity and protection from atherosclerosis [J].
Boucher, P ;
Gotthardt, M ;
Li, WP ;
Anderson, RGW ;
Herz, J .
SCIENCE, 2003, 300 (5617) :329-332
[3]   Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice [J].
Bruemmer, D ;
Collins, AR ;
Noh, G ;
Wang, W ;
Territo, M ;
Arias-Magallona, S ;
Fishbein, MC ;
Blaschke, F ;
Kintscher, U ;
Graf, K ;
Law, RE ;
Hsueh, WA .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (09) :1318-1331
[4]   Experimental techniques and models in the study of the development and treatment of abdominal aortic aneurysm [J].
Carrell, TWG ;
Smith, A ;
Burnand, KG .
BRITISH JOURNAL OF SURGERY, 1999, 86 (03) :305-312
[5]   Angiotensin II regulates oxygen consumption [J].
Cassis, L ;
Helton, M ;
English, V ;
Burke, G .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2002, 282 (02) :R445-R453
[6]   Mechanisms contributing to angiotensin II regulation of body weight [J].
Cassis, LA ;
Marshall, DE ;
Fettinger, MJ ;
Rosenbluth, B ;
Lodder, RA .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1998, 274 (05) :E867-E876
[7]   Role of metabolism and receptor responsiveness in the attenuated responses to Angiotensin II in mice compared to rats [J].
Cassis, LA ;
Huang, J ;
Gong, MC ;
Daugherty, A .
REGULATORY PEPTIDES, 2004, 117 (02) :107-116
[8]   Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor -/- mice [J].
Daugherty, A ;
Cassis, L .
THE METABOLIC SYNDROME X: CONVERGENCE OF INSULIN RESISTANCE, GLUCOSE INTOLERANCE, HYPERTENSION, OBESITY, AND DYSLIPIDEMIAS-SEARCHING FOR THE UNDERLYING DEFECTS, 1999, 892 :108-118
[9]   Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice [J].
Daugherty, A ;
Manning, MW ;
Cassis, LA .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (11) :1605-1612
[10]   Antagonism of AT2 receptors augments Angiotensin II-induced abdominal aortic aneurysms and atherosclerosis [J].
Daugherty, A ;
Manning, MW ;
Cassis, LA .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (04) :865-870